Biosimilar Basics: Payer Perspective

Update: 2024-06-19

Description

In this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective.

If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

Comments

In Channel

Q3 GPO Legislative Townhall

2025-10-0935:15

Inflation Reduction Act: Current State

2025-08-1409:28

Q2 GPO Legislative Townhall

2025-07-3149:22

Inflation Reduction Act: Overview

2025-07-2215:09

505(b)(2) Operationalizing in Practice - Provider Perspective

2025-05-1320:25

505(b)(2) Operationalizing in Practice - Pharmacist Perspective

2025-05-0110:32

505(b)(2) Billing and Reimbursement

2025-04-1739:31

505(b)(2) Landscape and Pipeline

2025-04-0332:36

505(b)(2) Basics

2025-03-1830:47

Buy and Bill: Practice Perspective

2025-02-0436:48

Buy and Bill: The Basics

2025-01-2218:21

GPO 101: Legislative Townhall

2025-01-0838:12

Biosimilar Basics: Payer Perspective

2024-06-1922:41

Biosimilar Basics: Legislation

2024-05-2316:27

Biosimilar Basics: Market Landscape

2024-05-0119:26

Biosimilar Basics: Overview

2024-04-1717:47

GPO Legislative Townhall December 2023: Part 11

2024-02-0808:24

GPO Legislative Townhall December 2023: Part 10

2024-02-0815:32

GPO Legislative Townhall December 2023: Part 9

2024-01-1112:30

GPO Legislative Townhall August 2023: Part 8

2023-11-2928:24

00:00

Biosimilar Basics: Payer Perspective

#box-pro-ellipsis-176682302591695{-webkit-line-clamp:2;}Biosimilar Basics: Payer Perspective

Biosimilar Basics: Payer Perspective

Cencora

Biosimilar Basics: Payer Perspective